Chuang Hao-Yuan's Form 4 filing
Belite Bio, Inc (BLTE) · filed Apr 13, 2026
- Accession no.
- 0001193125-26-152883
- Filed
- Apr 13, 2026
- Trade date
- Apr 9, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $1.13M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chuang Hao-YuanCIK 0001992008 | Director, Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | American depositary share | SSaleDisposed | −2,000 | $180.35F3 | −$360,700 | 98,000 | Direct | |
| Apr 9, 2026 | American depositary share | SSaleDisposed | −2,000 | $181.40F4 | −$362,800 | 96,000 | Direct | |
| Apr 9, 2026 | American depositary share | SSaleDisposed | −1,909 | $182.58F5 | −$348,545.22 | 94,091 | Direct | |
| Apr 9, 2026 | American depositary share | SSaleDisposed | −291 | $183.08F6 | −$53,276.28 | 93,800 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $180.00 to $180.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $181.00 to $181.80. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $182.00 to $182.89. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $183.00 to $183.21. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.